Literature DB >> 20118118

Gene selection in microarray survival studies under possibly non-proportional hazards.

Daniela Dunkler1, Michael Schemper, Georg Heinze.   

Abstract

MOTIVATION: Univariate Cox regression (COX) is often used to select genes possibly linked to survival. With non-proportional hazards (NPH), COX could lead to under- or over-estimation of effects. The effect size measure c=P(T(1)<T(0)), i.e. the probability that a person randomly chosen from group G(1) dies earlier than a person from G(0), is independent of the proportional hazards (PH) assumption. Here we consider its generalization to continuous data c' and investigate the suitability of c' for gene selection.
RESULTS: Under PH, c' is most efficiently estimated by COX. Under NPH, c' can be obtained by weighted Cox regression (WHE) or a novel method, concordance regression (CON). The least biased and most stable estimates were obtained by CON. We propose to use c' as summary measure of effect size to rank genes irrespective of different types of NPH and censoring patterns. AVAILABILITY: WHE and CON are available as R packages. CONTACT: georg.heinze@meduniwien.ac.at SUPPLEMENTARY INFORMATION: Supplementary Data are available at Bioinformatics online.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118118     DOI: 10.1093/bioinformatics/btq035

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  10 in total

1.  Ranking prognosis markers in cancer genomic studies.

Authors:  Shuangge Ma; Xiao Song
Journal:  Brief Bioinform       Date:  2010-11-18       Impact factor: 11.622

2.  A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Authors:  Ingrid Pabinger; Nick van Es; Georg Heinze; Florian Posch; Julia Riedl; Eva-Maria Reitter; Marcello Di Nisio; Gabriela Cesarman-Maus; Noémie Kraaijpoel; Christoph Carl Zielinski; Harry Roger Büller; Cihan Ay
Journal:  Lancet Haematol       Date:  2018-06-07       Impact factor: 18.959

3.  Estimation of odds of concordance based on the Aalen additive model.

Authors:  Torben Martinussen; Christian Bressen Pipper
Journal:  Lifetime Data Anal       Date:  2012-10-27       Impact factor: 1.588

4.  Unified methods for feature selection in large-scale genomic studies with censored survival outcomes.

Authors:  Lauren Spirko-Burns; Karthik Devarajan
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

5.  Gene selection using iterative feature elimination random forests for survival outcomes.

Authors:  Herbert Pang; Stephen L George; Ken Hui; Tiejun Tong
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2012 Sep-Oct       Impact factor: 3.710

6.  Increased metastasis with loss of E2F2 in Myc-driven tumors.

Authors:  Inez Yuwanita; Danielle Barnes; Michael D Monterey; Sandra O'Reilly; Eran R Andrechek
Journal:  Oncotarget       Date:  2015-11-10

7.  Time-Variant Genetic Effects as a Cause for Preterm Birth: Insights from a Population of Maternal Cousins in Sweden.

Authors:  Julius Juodakis; Jonas Bacelis; Ge Zhang; Louis J Muglia; Bo Jacobsson
Journal:  G3 (Bethesda)       Date:  2017-04-03       Impact factor: 3.154

8.  Joint Covariate Detection on Expression Profiles for Selecting Prognostic miRNAs in Glioblastoma.

Authors:  Chengqi Sun; Xudong Zhao
Journal:  Biomed Res Int       Date:  2017-03-20       Impact factor: 3.411

9.  Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.

Authors:  Zihang Zeng; Yanping Gao; Jiali Li; Gong Zhang; Shaoxing Sun; Qiuji Wu; Yan Gong; Conghua Xie
Journal:  Comput Struct Biotechnol J       Date:  2022-01-07       Impact factor: 7.271

10.  Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.

Authors:  B Goeppert; L Frauenschuh; M Zucknick; A Stenzinger; M Andrulis; F Klauschen; K Joehrens; A Warth; M Renner; A Mehrabi; M Hafezi; A Thelen; P Schirmacher; W Weichert
Journal:  Br J Cancer       Date:  2013-10-17       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.